560-RICR-10-10-2
A. In addition to the terms defined in R.I. Gen. Laws §§ 21-28.11-3, 21-28.6-3, and all other Parts of this Chapter, for this Part the following terms shall have the following meanings:
3. “Cannabis” or “Marijuana” means all parts of the plant cannabis sativa L., whether growing or not; the seeds of the plant; the resin extracted from any part of the plant; and every compound, manufacture, salt, derivative, mixture, or preparation of the plant, its seeds or resin, but shall not include the mature stalks of the plant, fiber produced from the stalks, oil or cake made from the seeds of the plant, any other compound, manufacture, salt, derivative, mixture, or preparation of mature stalks, (except the resin extracted from it), fiber, oil or cake, or the sterilized seed from the plant which is incapable of germination. Cannabis shall not include hemp as defined in R.I. Gen. Laws § 2-26-3. Cannabis sub-categories include but are not limited to:
a. “Cannabis infused products” means product infused with cannabis or an extract of cannabis that is intended for use or consumption other than by smoking or vaping, including but not limited to edible and ingestible/non-edible products.
c. “Dried cannabis” means the leaves and flowers of the cannabis plant after the wet harvested leaves and flowers of the cannabis plant have undergone the drying process and may be capable of combustion.
D. Retail cannabis establishments may only dispense products designated for retail sale to consumers as specified in the Cannabis Act and may only dispense products designated for medical use to qualified patients, registered primary caregivers, and authorized purchasers who possess a valid and unexpired registry identification card.
A. To have any cannabis product designated for retail sale, a product must:
C. The Commission will not designate any product as retail ready if:
2. Anything about the product targets or is appealing to minors.
A. For cannabis concentrate forms, the Commission will not designate a product as retail-ready cannabis if:
2. Unapproved additives have been added to the product, including but not limited to cutting agents or chemical such as nicotine.
A. For smokable product forms, the Commission will not designate a product as retail-ready cannabis if:
1. The product has been combined with tobacco, nicotine, caffeine, or any other substance not approved by the Commission.
A. For infused cannabis product forms, the Commission will not designate a product as retail-ready cannabis if the product:
6. Causes a reasonable consumer confusion as to whether the cannabis product is a trademarked product.
A. To have a cannabis product designated for medical use only, a product must:
2. Products eligible to be designated for medical use only include the following ingestible/non-edible cannabis products:
A. The following equivalency table shall be used to ascertain whether the amount of various forms of cannabis is compliant with the dried useable possession limits set forth in the Cannabis Act, the Medical Marijuana Act and any regulations promulgated thereunder.
| Cannabis Flower Weight (Grams) | Cannabis Flower Weight (Ounces) | Equivalent Number of 10mgs of THC Single Serving Units |
| 140 g | 5 oz | 420 THC single serving units |
| 70 g | 2.5 oz | 210 THC single serving units |
| 28 g | 1 oz | 84 THC single serving units |
| 7 g | 0.25 oz | 21 THC single serving units |
| 1 g | 0.035 oz | 3 THC single serving units |
| Cannabis Flower Weight (Grams) | Cannabis Flower Weight (Ounces) | Equivalent grams of Concentrate |
| 140 g | 5 oz | 42 g |
| 70 g | 2.5 oz | 21 g |
| 28 g | 1 oz | 8.44 g |
| 7 g | 0.25 oz | 2.1 g |
| 1 g | 0.035 oz | 0.3 g |
| Wet Flower Weight (Grams) | Wet Flower Weight (Ounces) | Dry Flower Weight (20% of Wet Flower Weight) |
| 1400 g | 50 oz | 280 g or 10 oz |
| 1,050 g | 37.5 oz | 210 g or 7.5 oz |
| 700 g | 25 oz | 140 g or 5 oz |
| 350g | 12.5 ounces | 70 g or 2.5 oz |
D. In addition to any other requirements pursuant to § 2.7 of this Part, any package containing retail-ready cannabis product must:
E. Exit Package
F. Additional Packaging Requirements for Retail-Ready Edible and Ingestible Cannabis-Infused Products
4. Multiple packages may be bundled and sold together so long as the:
6. Retail-Ready Edible Cannabis-Infused Products in Liquid Form
G. Additional Packaging Requirements for Retail-Ready Cannabis Concentrates Intended for Inhalation
H. Additional Packaging Requirements for Retail-Ready Cannabis-Infused Products intended for Topical Application
I. Additional Packaging Requirements for Retail Ready Cannabis Infused Ingestible Tinctures
C. Cannabis retail establishment licensees are responsible for ensuring all cannabis products are retail-ready prior to sale.
B. Labeling text must be:
E. All packages containing retail-ready cannabis products must be clearly labeled with the following information:
3. The cannabinoid profile as provided by a licensed cannabis testing laboratory;
4. A Commission-selected universal warning symbol must appear on the front or most predominantly displayed area of the package, no smaller in size than one (1) inch by one (1) inch;
F. Additional Labeling Requirements for Retail-Ready Cannabis Infused Products:
G. All packages containing retail-ready cannabis products must be labeled with the following information, which may be placed on an insert, stated in a peel-back accordion, expandable or extendable label style so long as the label can be easily identified by a consumer as containing important information, or may be contained by a Commission-approved QR code:
8. A statement that the cannabis in the product has been tested by a regulated cannabis testing facility and has passed all required contaminant tests.
A. Unless deemed impracticable by the Commission, each single standardized serving unit of a cannabis-infused product shall be marked, stamped, imprinted or individually wrapped with a Commission-selected universal symbol directly on at least one side of the cannabis-infused product in a manner to cause the universal symbol to be distinguishable and easily recognizable. The universal symbol marking shall:
B. Unless specifically determined by the Commission to be impracticable, the following categories of cannabis-infused products are considered to be per se practicable to mark with the universal symbol:
5. Pressed pills and capsules.
A. If the immediate container holding the retail-ready cannabis product is too small to fit all of the label information required by this Section, the following minimum information, in accordance with this Section, is required to be placed on a label that is securely affixed to the immediate container:
C. If the immediate container and secondary container are not child-resistant, both containers must be placed into a child-resistant exit package in compliance with § 2.6(E) upon sale.
A. Any logo or graphic that appears on retail-ready packaging must not:
11. Violate any state or federal trademark law or regulation.
A. Warnings on all retail-ready cannabis products must:
B. The following warnings must be displayed on all retail-ready cannabis products, preceded either collectively or individually by the term “Warning”:
5. For cannabis products intended to be smoked or vaporized:
6. For all cannabis-infused products, it must state in slightly larger or bold font as to stand out from surrounding text, with priority placement:
7. For all cannabis-infused topical products, it must state:
B. Permitted Advertising
2. Advertising may include:
a. Online media, including cannabis establishment websites, video advertisements, social media, and pop-up advertisements;
3. Advertising must clearly and conspicuously include:
4. Advertising shall not:
B. All information related to the acquisition, propagation, cultivation, transfer, manufacturing, processing, testing, storage, destruction, wholesale and/or retail sale of all cannabis plants and inventory possessed by licensees and/or distributed at retail to consumers in accordance with the Cannabis Act, the Medical Marijuana Act and these Regulations must be kept up to date in the cannabis seed-to-sale tracking system, including but not limited to:
16. A complete inventory, including but not limited to:
A. Unique identifier tags shall be placed in a manner to clearly display their association with a particular plant, plant material, or cannabis product as approved by the Commission. For example:
B. All cannabis inventory, including but not limited to immature plants, seeds, cannabis, cannabis derivatives, cannabis currently being processed, cannabis products and waste must be tagged with the following information unless otherwise approved by the Commission:
C. Each mature cannabis plant must be physically tagged and tracked individually with the following information unless otherwise approved by the Commission:
D. External Inventory Sources
E. Quality Control Sampling
1. Licensees shall utilize the cannabis seed-to-sale tracking system to dispense cannabis for quality control sampling purposes so long as the quality control sample:
F. Trade Samples
1. Licensees shall utilize the cannabis seed-to-sale tracking system to transfer, accept and dispense cannabis for trade sample purposes so long as:
A. Other than transfers from external sources as described in § 2.10(D) of this Part, licensed cannabis cultivators shall only sell to and receive cannabis and cannabis products from entities licensed pursuant to the Cannabis Act and the Medical Marijuana Act and in accordance with the permitted activities of each license type. R.I. Gen. Laws § 21-28.11-7(j).
2. Licensed cannabis cultivators may only receive cannabis and cannabis products from a licensed cannabis establishment if the receipt is pursuant to a formal agreement;
B. Licensed cannabis product manufacturers may only purchase or receive cannabis for processing from licensed cannabis cultivators and transfer or sell cannabis products to entities licensed pursuant to the Cannabis Act and the Medical Marijuana Act. R.I. Gen. Laws § 21-28.11-9(a).
C Other than transfers from external sources as set forth in § 2.10(D) of this Part, as applicable, a licensed compassion center, hybrid cannabis retailer, and/or other type of retail cannabis establishment shall only purchase or otherwise receive cannabis or cannabis products from a Rhode Island licensed cannabis cultivator or licensed cannabis product manufacturer with which it has a formal agreement.
D. The requirements for a formal agreement shall be as follows:
1. A written executed contract or purchase order shall be required for all sales or services and shall contain the following minimum terms:
E. Permitted and Prohibited Sales and Transfers
1. Sales to adult-use consumers are only permitted if those intended purchasers are at least twenty-one (21) years of age and present a valid government issued identification card. Only cannabis and cannabis products that have been designated by the Commission in accordance with § 2.4 of this Part may be sold or distributed.
3. Sales to out-of-state patients
B. If the licensed cannabis establishment is notified by the Commission that the cannabis seed-to-sale tracking system is not available, the licensed cannabis establishment will be provided with direction as to alternative inventory control measures, which may include but may not be limited to the licensed cannabis establishment being directed to:
B. The Commission’s general security requirements include that:
3. The outside perimeter of a cannabis establishment shall be lighted as follows:
C. Security Alarm Requirements
D. Video Surveillance Requirements
1. Each licensed cannabis establishment must have a fully operational video surveillance and camera recording system of an appropriate commercial standard as deemed acceptable by the Commission with appropriate protocols, which shall, at a minimum, comply with all of the below requirements:
E. Placement of Cameras and Required Camera Coverage
F. Location and Maintenance of Surveillance Equipment
G. Emergency Plan
H. Security-Related Record-Keeping
1. The licensed cannabis establishment shall maintain the following documentation on-site and with digital back-up for a period of at least twenty-four (24) months:
I. Emergency Notifications and Reports
2. Immediately upon discovery of the event, or as a soon as possible following a conclusion of a security incident, the licensed cannabis establishment shall provide telephone notification to the appropriate municipal and/or state law enforcement authorities and first responders regarding any of the following “emergency events”:
B. Operations Manual. Each licensed cannabis establishment shall develop, implement, and maintain on the premises an operations manual with standard operating procedures which address, at a minimum, all of the following subject areas and requirements:
2. Procedures to ensure accurate record-keeping, including but not limited to protocols to ensure that:
b. All dispensing and sales transactions:
3. Required Employee, Agent, and Volunteer Training.
a. In accordance with R.I. Gen. Laws §§ 21-28.11-5(b)(4), (b)(7), (b)(14), 21-28.6-12(f)(14) and 21-28.6-16(b), each licensed cannabis establishment shall develop, implement, and maintain on the premises an on-site training curriculum, or enter into contractual relationships with outside resources capable of meeting employee, agent, and, if applicable, volunteer training needs. Each employee, agent or volunteer, at the time of their initial appointment and every year thereafter, shall receive, at a minimum, training in the following:
(4) For compassion centers and hybrid cannabis retailers:
4. Policies and procedures for ensuring that any outdated, damaged, deteriorated, mislabeled, or contaminated cannabis is quarantined from other cannabis and destroyed.
12. For compassion centers and hybrid cannabis retailers only:
C. Personnel Records
1. Each licensed cannabis establishment shall maintain a personnel record for each employee, agent or volunteer for a period of at least one (1) year after termination of the individual’s affiliation with the licensed establishment. Said personnel record shall contain the following minimum documentation and information:
D. Additional Records to be Maintained
1. In addition to all other specific record-keeping requirements of the Cannabis Act, the Medical Marijuana Act and all associated regulations, the licensed cannabis establishment shall maintain the following records for a minimum of five (5) years:
2. All records maintained by a compassion center and/or hybrid cannabis retail licensee which pertain to one or more registered qualifying patients, registered primary caregivers, or authorized purchasers shall be:
E. Records Storage and Responsibility for Loss of Records and Data
A. Authorized Transport Vehicle Requirements
3. To qualify as an “authorized transport vehicle” the licensed cannabis establishment shall use a vehicle meeting all the following criteria:
B. Detailed Transport Manifests
3. The detailed transport manifest shall include the following minimum information:
C. Authorized Transport Requirements
6. During all authorized transports:
A. Home delivery of cannabis and cannabis products by licensed retail cannabis retailers shall be permitted provided the licensee applies for and receives a variance from the Commission and that the cannabis and cannabis products are sold and delivered in compliance with the Cannabis Act, the Medical Marijuana Act, these Regulations and all other applicable laws, including but not limited to the following requirements:
B. Transportation requirements for home delivery include but are not limited to the following:
C. Home delivery product and payment requirements include but are not limited to:
A. Curbside pickup activities of cannabis and cannabis products by a licensed retail establishment shall be permitted provided the licensee applies for and receives a variance from the Commission and that cannabis and cannabis products are sold in compliance with the Cannabis Act, the Medical Marijuana Act and these Regulations, including but not limited to the following requirements:
B. Requirements for Volatile Solvent-Based Hydrocarbon Extraction
2. All volatile solvent-based hydrocarbon extraction manufacturing shall:
b. Utilize the following permissible volatile solvent-based hydrocarbon extraction substances and be accompanied by a certificate of analysis, maintained in accordance with § 2.20(D) of this Part, which establishes that said substances have a minimum purity level of ninety-nine percent (99.0%):
C. Volatile Solvent-Based Hydrocarbon Extraction Application
1. The Commission’s approval process for volatile solvent-based hydrocarbon extraction applications shall consist of:
2. Pre-Approval
a. Licensees eligible to perform volatile solvent-based hydrocarbon extraction may apply to the Commission on forms prescribed by the Commission which include but are not limited to the following:
(5) Design plans stamped and sealed by Rhode Island Registered Professional Engineer(s) and a Rhode Island Registered Architect, where applicable, who will ultimately provide a final certification pursuant to § 2.20(C)(4)(a) of this Part, for any and all modifications and/or additions to the licensee’s facility including but not limited to:
4. Final Approval: An eligible licensee which has obtained the Commission’s pre-approval and has implemented the facility modifications pursuant to the design plan may apply for final approval on forms prescribed by the Commission which include but are not limited to the following requirements:
D. Standard Operating Procedures
1. All licenses conducting volatile solvent-based hydrocarbon extraction shall develop standard operating procedures which demonstrate compliance with all applicable laws and regulations and specifically address the following:
d. Incident reporting for instances where the operator does not follow the stated standard operating procedures which identifies:
f. Record-keeping of:
A. Outreach activities to registered qualifying patients, registered primary caregivers, and authorized purchasers shall, at a minimum, include:
B. The facility must meet the following minimum sanitation specifications, including having and maintaining:
B. The use of pesticides on cannabis plants in Rhode Island by licensed cannabis establishments will not be considered a violation of these Regulations provided that the products satisfy all of the following criteria:
F. Test results
G. Failed Test Batches
H. Retesting
1. In the event of a retest, the following protocol shall be followed:
I. Remediation
A. The Commission or RIDOH may require a cannabis establishment to recall any cannabis or cannabis product that the cannabis establishment has sold or transferred upon a finding that circumstances exist that pose a risk to public health, safety and welfare. Under such circumstances:
B. A recall may be based on, without limitation, evidence that the cannabis or cannabis product:
D. If the Commission finds that a recall is required, the Commission:
A. In accordance with R.I. Gen. Laws §§ 21-28.11-5(b)(27)(ii), (vi), and 21-28.11-11(a), the Commission is authorized to promulgate regulations regarding random sample testing to ensure quality control, including ensuring that cannabis and cannabis products are accurately labeled for THC content and any other product profile, and allows the Commission to establish quality assurance mechanisms to ensure the accuracy of product testing and labeling. The quality assurance testing program set forth in this Section is promulgated in accordance with the Commission’s statutory authority over licensed cannabis establishments as set forth in the Cannabis Act, the Medical Marijuana Act, and these Regulations.
C. Frequency of Cannabis and Cannabis Product Sampling
D. Collection of Cannabis and Cannabis Product Samples
4. No more than the minimum sufficient quantity of each product shall be collected such that no fewer than three (3) cannabis testing labs can analyze the samples for all analytes specified by the Commission, with enough material held in reserve for at least one (1) additional series of tests by a laboratory. Analytes tested may include, but are not limited to, those required by 216-RICR-60-05-6 for retail sale.
10. Collected samples shall be randomly assigned to cannabis testing laboratories at the homogenizing location.
A. Cannabis testing laboratories shall: